Schulman Robin reported acquisition or exercise transactions in this Form 4 filing.
Quantinuum Inc. updated an insider equity award for its CLO & Corporate Secretary, Robin Schulman. On July 17, 2026, Schulman received a grant of 125,000 restricted stock units (RSUs), each representing a contingent right to one share of Class A Common Stock, vesting under the applicable grant agreement. Following this award, Schulman directly holds 125,000 shares/RSUs reported in this filing.
Schulman Robin reported acquisition or exercise transactions in this Form 4 filing.
Quantinuum Inc. reported that its CLO & Corporate Secretary, Robin Schulman, received an equity award on July 17, 2026. Schulman was granted 78,125 restricted stock units (RSUs), each representing a contingent right to receive one share of Class A Common Stock. Following this grant, Schulman is reported as directly holding 78,125 shares/RSUs, which will vest according to the applicable grant agreement.
Quantinuum Inc. filed an initial Form 3 identifying Robin Schulman, the company’s CLO & Corporate Secretary, as a reporting insider. The filing reports no stock transactions, derivative activities, or holdings entries in the structured data for Schulman at the time of this report.
BlackRock Portfolio Management LLC reports beneficial ownership of Class A Stock of INC CLASS A on a Schedule 13G. The firm beneficially owns 2,259,347 shares, representing 6.9% of the outstanding Class A Stock. Of these, it has sole power to vote 2,118,996 shares and sole power to dispose of 2,259,347 shares, with no shared voting or dispositive power. Various underlying clients have rights to dividends or sale proceeds, but no individual client holds more than five percent of the total outstanding common shares.
Quantinuum Inc. reports that Capital World Investors holds 4,558,976 shares of Common Stock, representing 13.9% of the company as of 06/30/2026. The filing states the 4,558,976 shares reflect sole voting and dispositive power. The filing cites 32,862,895 shares believed to be outstanding as context.
Quantinuum Inc. shareholders Cambridge Quantum Holdings Limited, CQ Invest I LLC, Ilyas Khan and Waseem Shiraz filed a joint Schedule 13G reporting concerted beneficial ownership positions. The filing states 82,884,823 shares of Class A common stock are issuable upon conversion of Common Units and Class B shares, representing approximately 71.5% of Class A on the conversion basis as reported in the issuer's prospectus dated June 3, 2026.
The filing discloses that Cambridge Quantum Holdings Limited directly holds 82,353,103 Common Units and CQ Invest I LLC holds 531,720 Common Units. Mr. Khan directly holds 480,511 Class A shares and Mr. Shiraz directly holds 27,001 Class A shares in their personal capacities.
Quantinuum Inc. director Prineha Narang reported new equity activity in Class A Common Stock. On June 5, 2026, Narang made an open-market purchase of 200 shares at $60.00 per share, bringing direct holdings to 6,033 shares.
On June 4, 2026, Narang also received an award of 5,833 restricted stock units, each representing one share of Class A Common Stock. According to the award terms, these RSUs will vest in three equal annual installments beginning on June 5, 2027, adding a long-term equity component to the director’s compensation.
Quantinuum Inc. director Joseph Jimenez reported new share acquisitions. He made an open-market purchase of 66,665 shares of Class A Common Stock at $60.00 per share on June 5, 2026, bringing his directly held stake to 72,498 shares.
On June 4, 2026, he also received a grant of 5,833 restricted stock units, each representing one future share of Class A Common Stock. These RSUs vest in three equal annual installments beginning on June 5, 2027, aligning part of his compensation with the company’s long-term performance.
Quantinuum Inc.’s Chief Financial Officer Nitesh Sharan reported several acquisitions of Class A Common Stock. He received 289,798 restricted shares in a recapitalization transaction and a further 44,548 restricted shares as a stock award. These awards were made at no cash cost to him.
After these awards, he made an open-market purchase of 6,500 shares at $60.00 per share. Following these transactions, he directly owns 340,846 Class A Common Stock shares. One award was completed before Quantinuum’s initial public offering and is being reported under Rule 16a-2(a).
Quantinuum Inc. director Hal Barron significantly increased his direct stake through a large open-market purchase and a new equity award. On Class A Common Stock, he bought 250,000 shares in the open market at $60.00 per share, bringing his direct holdings to 255,833 shares after the trade.
He also received an award of 5,833 restricted stock units, each representing one future share of Class A Common Stock. These RSUs will vest in three equal annual installments beginning on June 5, 2027, adding a long-term, performance-aligned component to his ownership.